(Q45981857)

18 December 2017

title

Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension. (English)

1 reference

18 December 2017

author name string

Takayoshi Tsutamoto

1

1 reference

18 December 2017

Toshinari Tanaka

2

1 reference

18 December 2017

Keizo Nishiyama

3

1 reference

18 December 2017

Masayuki Yamaji

4

1 reference

18 December 2017

Chiho Kawahara

5

1 reference

18 December 2017

Masanori Fujii

6

1 reference

18 December 2017

Takashi Yamamoto

7

1 reference

18 December 2017

Minoru Horie

8

1 reference

18 December 2017

publication date

5 June 2009

1 reference

18 December 2017

published in

Hypertension Research

1 reference

18 December 2017

volume

32

1 reference

18 December 2017

issue

8

1 reference

18 December 2017

page(s)

670-674

1 reference

18 December 2017

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators

cites work

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Efficacy of eplerenone added to renin-angiotensin blockade in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

"Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

RISE IN PLASMA CONCENTRATION OF ALDOSTERONE DURING LONG-TERM ANGIOTENSIN II SUPPRESSION

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Effectiveness of aldosterone blockade in patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Combination therapy with aldosterone blockade and renin-angiotensin inhibitors confers organ protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

The incidence and implications of aldosterone breakthrough

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Aldosterone breakthrough during angiotensin II receptor blockade in hypertensive patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Aldosterone regulation of T-type calcium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Serum aldosterone and the incidence of hypertension in nonhypertensive persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarctio

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocard

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Expression of T-type Ca(2+) channels in ventricular cells from hypertrophied rat hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Reexpression of T-type Ca2+ channel gene and current in post-infarction remodeled rat left ventricle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Left ventricular hypertrophy and clinical outcomes in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES])

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

7 January 2021

Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

7 January 2021

Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

7 January 2021

Aldosterone breakthrough during therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

7 January 2021

Influence of heart rate on mortality among persons with hypertension: the Framingham Study

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

7 January 2021

Increased survival after long-term treatment with mibefradil, a selective T-channel calcium antagonist, in heart failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

7 January 2021

T-type Ca2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

7 January 2021

Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.78

7 January 2021

Identifiers

DOI

10.1038/HR.2009.78

1 reference

18 December 2017

Dimensions Publication ID

1030129539

0 references

1 reference

18 December 2017